Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the USA.
| Product | Description | |
|---|---|---|
| Tenofovir Alafenamide | Tenofovir Alafenamide is a prodrug of Tenofovir, which is a reverse transcriptase inhibitor used to treat HIV and Hepatitis B. Antiviral. Group: Pharmaceutical. Alternative Names: (S)-isopropyl 2-(((S)-((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(phenoxy)phosphoryl)amino)propanoate; GS7340; GS-7340; GS 7340; Tenofovir alafenamide. CAS No. 379270-37-8. Pack Sizes: 200 mg. Product ID: B0084-463638. Molecular formula: C21H29N6O5P. Mole weight: 476.47. Custom synthesis is available. Send your inquiries for more information. |  London |
| Tenofovir Alafenamide-[d5] (diastereomers) | An isotope labelled derivative of Tenofovir alafenamide. Tenofovir alafenamide is a nucleotide reverse transcriptase inhibitor and a prodrug of tenofovir. Tenofovir is an antiretroviral used for HIV treatment. Group: Pharmaceutical. Alternative Names: Tenofovir Alafenamide-d5 (diastereomers); GS 7171-d5; 1-Methylethyl Ester N-[[[(1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl] phenoxyphosphinyl]-L-alanine-d5. CAS No. 2131003-68-2. Pack Sizes: 10 mg. Product ID: BLP-006020. Molecular formula: C21H24D5N6O5P. Mole weight: 481.5. Custom synthesis is available. Send your inquiries for more information. | London |
| Tenofovir alafenamide hemifumarate | Tenofovir alafenamide hemifumarate, also known as Tenofovir alafenamide fumarate (2:1), is a nucleotide reverse transcriptase inhibitor (NRTIs) and a novel prodrug of tenofovir. By blocking reverse transcriptase, TAF prevents HIV from multiplying and can reduce the amount of HIV in the body. Group: Pharmaceutical. Alternative Names: Isopropyl ((S)-((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(phenoxy)phosphoryl)-L-alaninate hemifumarate; TAF; GS734; GS-734; GS 734; GS 7340; GS-7340; GS7340; Tenofovir alafenamide fumarate (2:1). CAS No. 1392275-56-7. Pack Sizes: 200 mg. Product ID: B0084-470850. Molecular formula: C46H62N12O14P2. Mole weight: 1069.02. Custom synthesis is available. Send your inquiries for more information. | London |
| Tenofovir Alafenamide PMPA Impurity | One impurity of Tenofovir, which is an acyclic phosphonate nucleotide derivative, could be used in antiviral treatment as an everse transcriptase inhibitor. Group: Pharmaceutical. Alternative Names: Tenofovir Dimer; Bis((((R)-1-(6-Amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)diphosphonic Acid. CAS No. 1607007-18-0. Pack Sizes: 10 mg. Product ID: B2694-172640. Molecular formula: C18H26N10O7P2. Mole weight: 556.41. Custom synthesis is available. Send your inquiries for more information. | London |
| Tenofovir disoproxil soproxil dimer | Tenofovir disoproxil soproxil dimer is an impurity of Tenofovir Disoproxil Fumarate, which is a potent reverse transcriptase inhibitor used to treat chronic hepatitis B and to prevent and treat HIV/AIDS. Group: Pharmaceutical. Alternative Names: O,O,O-Tris(isopropoxycarbonyloxymethyl) {[{(2R,2'R)-[methylenebis(azanediyl)]bis(9H-purine-9,6-diyl)}bis(propane-1,2-diyl)]bis(oxy)}bis(methylene)diphosphonate; Tri-POC Tenofovir Dimer; 2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[(1R)-2-[6-[[[[9-[(2R)-5-hydroxy-2,11-dimethyl-5-oxido-9-oxo-3,6,8,10-tetraoxa-5-phosphadodec-1-yl]-9H-purin-6-yl]amino]methyl]amino]-9H-purin-9-yl]-1-methylethoxy]methyl]-, 1,9-bis(1-methylethyl) ester, 5-oxide; 5-[[(1R)-2-[6-[[[[9-[(2R)-5-Hydroxy-2,11-dimethyl-5-oxido-9-oxo-3,6,8,10-tetraoxa-5-phosphadodec-1-yl]-9H-purin-6-yl]amino]methyl]amino]-9H-purin-9-yl]-1-methylethoxy]methyl]-2,4,6,8-tetraoxa-5-phosphanonanedioic Acid 1,9-Bis(1-methylethyl) Ester 5-Oxide; Bis(1-methylethyl) 5-{[(1R)-2-(6-{[({9-[(2R)-5-hydroxy-2,11-dimethyl-5,9-dioxo-3,6,8,10-tetraoxa-5-λ5-phosphadodecyl]-9H-purin-6-yl}amino)methyl]amino}-9H-purin-9-yl)-1-methylethoxy]methyl}-5-oxo-2,4,6,8-tetraoxa-5-λ5-phosphanonanedioate; Tenofovir di- and monosoproxil heterodimer; Tenofovir Disoproxil Fumarate IP Impurity I. CAS No. 1093279-77-6. Pack Sizes: 5 mg. Product ID: B1707-483049. Molecular formula: C34H52N10O17P2. Mole weight: 934.78. Custom synthe | London |
| Tenofovir Disoproxil USP Related Compound E | Tenofovir Disoproxil Related Compound E is an impurity of Tenofovir Disoproxil Fumarate, which is a potent reverse transcriptase inhibitor used to treat chronic hepatitis B and to prevent and treat HIV/AIDS. Group: Pharmaceutical. Alternative Names: O-Isopropoxycarbonyloxymethyl hydrogen (R)-[1-(6-amino-9H-purin-9-yl)prop-2-yloxy]methylphosphonate; Mono-POC Tenofovir; (8R)-9-(6-Amino-9H-purin-9-yl)-5-hydroxy-8-methyl-2,4,7-trioxa-5-phosphanonanoic Acid 1-Methylethyl Ester 5-Oxide; Tenofovir Monoisoproxil; Tenofovir isoproxil monoester; 2,4,7-Trioxa-5-phosphanonanoic acid, 9-(6-amino-9H-purin-9-yl)-5-hydroxy-8-methyl-, 1-methylethyl ester, 5-oxide, (8R)-; Tenofovir disoproxil impurity E; ((((((R)-1-(6-Amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(hydroxy)phosphoryl)oxy)methyl isopropyl carbonate; USP Tenofovir Disoproxil Related Compound E; Tenofovir Disoproxil Related Compound E; (1-methylethyl) (8R)-9-(6-amino-9H-purin-9-yl)-5-hydroxy-8-methyl-5-oxo-2,4,7-trioxa-5-λ5-phosphanonanoate; Tenofovir monosoproxil; Tenofovir Disoproxil Fumarate IP Impurity A. CAS No. 211364-69-1. Pack Sizes: 5 mg. Product ID: B2694-263085. Molecular formula: C14H22N5O7P. Mole weight: 403.33. Custom synthesis is available. Send your inquiries for more information. | London |
| Tenofovir Disoproxil USP Related Compound H | Tenofovir Disoproxil USP Related Compound H is an impurity of Tenofovir Disoproxil Fumarate, which is a potent reverse transcriptase inhibitor used to treat chronic hepatitis B and to prevent and treat HIV/AIDS. Group: Pharmaceutical. Alternative Names: O,O-Bis(isopropoxycarbonyloxymethyl) {(R)-[1-[(6-isopropoxycarbonylamino)-9H-purin-9-yl]propan-2-yloxy]}methylphosphonate; USP Tenofovir Disoproxil Related Compound H; Tenofovir disoproxil related compound H; Tenofovir Disoproxil Isopropoxycarbonyl; Tenofovir Related Compound H; 5-[[(1R)-1-Methyl-2-[6-[(isopropoxycarbonyl)amino]-9H-purin-9-yl]ethoxy]methyl]-2,4,6,8-tetraoxa-5-phosphanonanedioic Acid Bis(1-methylethyl) Ester 5-Oxide; (R)-Isopropyl (9-(2-((bis(((isopropoxycarbonyl)oxy)methoxy)phosphoryl)methoxy)propyl)-9H-purin-6-yl)carbamate; 2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[(1R)-1-methyl-2-[6-[[(1-methylethoxy)carbonyl]amino]-9H-purin-9-yl]ethoxy]methyl]-, 1,9-bis(1-methylethyl) ester, 5-oxide. CAS No. 1244022-54-5. Pack Sizes: 2 mg. Product ID: B1707-483052. Molecular formula: C23H36N5O12P. Mole weight: 605.54. Custom synthesis is available. Send your inquiries for more information. | London |
| Tenofovir Related Compound 1 | One impurity of Tenofovir, which is an acyclic phosphonate nucleotide derivative, could be used in antiviral treatment as an everse transcriptase inhibitor. Group: Pharmaceutical. Alternative Names: 9-[(2R)-2-(diphenoxyphosphorylmethoxy)propyl]purin-6-amine. CAS No. 342631-41-8. Pack Sizes: 20 mg. Product ID: B1707-483065. Molecular formula: C21H22N5O4P. Mole weight: 439.41. Custom synthesis is available. Send your inquiries for more information. | London |
| Tenofovir Related Compound 2 | An impurity of Tenofovir, which is a potent reverse transcriptase inhibitor used to treat chronic hepatitis B and to prevent and treat HIV/AIDS. Group: Pharmaceutical. Alternative Names: Tenofovir Phenol; Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, monophenyl ester; Phenyl hydrogen [(R)-1-(6-amino-9H-purin-9-yl)propan-2-yloxy]methylphosphonate; (R)-Phenyl hydrogen (((1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphonate. CAS No. 379270-35-6. Pack Sizes: 25 g. Product ID: B2694-483066. Molecular formula: C15H18N5O4P. Mole weight: 363.32. Custom synthesis is available. Send your inquiries for more information. | London |
| Tenofovir soproxil carbamate analog | Tenofovir soproxil carbamate analog is an impurity of Tenofovir Disoproxil Fumarate, which is a potent reverse transcriptase inhibitor used to treat chronic hepatitis B and to prevent and treat HIV/AIDS. Group: Pharmaceutical. Alternative Names: O-Isopropoxycarbonyloxymethyl hydrogen (R)-[1-[(6-isopropoxycarbonylamino)-9H-purin-9-yl]propan-2-yloxy]methylphosphonate; Isopropyl (9-((2R)-2-((hydroxy(((isopropoxycarbonyl)oxy)methoxy)phosphoryl)methoxy)propyl)-9H-purin-6-yl)carbamate; Mono-POC Tenofovir 6-Isopropyl Carbamate; (8R)-9-(6-Isopropylaminocarbamate-9H-purin-9-yl)-5-hydroxy-8-methyl-2,4,7-trioxa-5-phosphanonanoic Acid 1-Methylethyl Ester 5-Oxide; Tenofovir Disoproxil Fumarate IP Impurity E; Tenofovir Impurity E; (1-methylethyl) (8R)-5-hydroxy-8-methyl-9-(6-{[(1-methylethoxy)carbonyl]amino}-9H-purin-9-yl)-5-oxo-2,4,7-trioxa-5-λ5-phosphanonanoate. CAS No. 1244022-56-7. Pack Sizes: 1 mg. Product ID: B2694-483053. Molecular formula: C18H28N5O9P. Mole weight: 489.43. Custom synthesis is available. Send your inquiries for more information. | London |
| Tenofovir soproxil dimer | Tenofovir soproxil dimer is an impurity of Tenofovir Disoproxil Fumarate, which is a potent reverse transcriptase inhibitor used to treat chronic hepatitis B and to prevent and treat HIV/AIDS. Group: Pharmaceutical. Alternative Names: O,O-Bis(isopropoxycarbonyloxymethyl) {[{(2R,2'R)-[methylenebis(azanediyl)]bis(9H-purine-9,6-diyl)}bis(propane-1,2-diyl)]bis(oxy)}bis(methylene)bis(hydrogen phosphonate); ((Hydroxy((((2R)-1-(6-((((9-((2R)-2-((hydroxy(((isopropoxycarbonyl)oxy)methoxy)phosphoryl)methoxy)propyl)-9H-purin-6-yl)amino)methyl)amino)-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphoryl)oxy)methyl isopropyl carbonate; 2,4,7-Trioxa-5-phosphanonanoic acid, 5-hydroxy-9-[6-[[[[9-[(2R)-5-hydroxy-2,11-dimethyl-5-oxido-9-oxo-3,6,8,10-tetraoxa-5-phosphadodec-1-yl]-9H-purin-6-yl]amino]methyl]amino]-9H-purin-9-yl]-8-methyl-, 1-(1-methylethyl) ester, 5-oxide, (8R)-; Tenofovir Mono POC Dimer; Tenofovir monosoproxil dimer; Bis(1-methylethyl) 9,9'-[methylenebis(imino-9H-purine-6,9-diyl)]bis[(8R)-5-hydroxy-8-methyl-5-oxo-2,4,7-trioxa-5-λ5-phosphanonanoate]; Tenofovir Disoproxil Fumarate IP Impurity F. CAS No. 1962114-92-6. Pack Sizes: 1 mg. Product ID: B1707-483082. Molecular formula: C29H44N10O14P2. Mole weight: 818.68. Custom synthesis is available. Send your inquiries for more information. | London |
| Diethyl Tenofovir | One impurity of Tenofovir, which is an acyclic phosphonate nucleotide derivative, could be used in antiviral treatment as an everse transcriptase inhibitor. Group: Pharmaceutical. Alternative Names: (R)-9-[2-(Diethylphosphonomethoxy)propyl] Adenine; P-[[(1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]phosphonic Acid Diethyl Ester; [[(1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]phosphonic Acid Diethyl Ester. CAS No. 180587-75-1. Pack Sizes: 100 mg. Product ID: B1707-234697. Molecular formula: C13H22N5O4P. Mole weight: 343.33. Custom synthesis is available. Send your inquiries for more information. | London |
| racemic Tenofovir-[d7] | A labelled form of rac-Tenofovir. Tenofovir is an acyclic phosphonate nucleotide derivative used in antiviral treatment as an everse transcriptase inhibitor. Group: Pharmaceutical. Alternative Names: racemic Tenofovir-d7; rac-Tenofovir-d7; [(1R)-2(6-Amino-9H-purin-9-yl)-1-methylethoxy-d7]methyl]phosphonic Acid; (R)-9-(2-Phosphonomethoxypropyl)adenine-d7. Pack Sizes: 5 mg. Product ID: BLP-004089. Molecular formula: C9H7D7N5O4P. Mole weight: 294.26. Custom synthesis is available. Send your inquiries for more information. | London |
| Bictegravir | Bictegravir is a novel, potent inhibitor of HIV-1 integrase with an IC50 of 7.5 nM for strand transfer activity. Bictegravir is a drug of the integrase inhibitor class that was copied from Dolutegravir by scientists at Gilead Sciences. Bictegravir also inhibits HIV-1 viral infection in MT-2 and MT-4 cells, CD4+ T cells, and macrophages (EC50s = 1.5, 2.5, 1.5, and 6.6 nM, respectively) without exhibiting cytotoxicity (CC50s = 10.3, 3.7, 13, and 29.8 μM, respectively). In 2016, bictegravir was in a Phase 3 trial as part of a single tablet regimen in combination with tenofovir alafenamide (TAF) and emtricitabine (FTC) for the treatment of HIV-1 infection. Group: Pharmaceutical. Alternative Names: GS-9883; GS 9883; GS9883. CAS No. 1611493-60-7. Pack Sizes: 100 mg. Product ID: B2693-058383. Molecular formula: C21H18F3N3O5. Mole weight: 449.39. Custom synthesis is available. Send your inquiries for more information. | London |
| Cobicistat | Cobicistat is a potent inhibitor of cytochrome P450 3A enzymes, including the important CYP3A4 subtype. It also inhibits intestinal transport proteins, increasing the overall absorption of several HIV medications, including atazanavir, darunavir and tenofovir alafenamide fumarate. Uses: Anti-hiv agents. Group: Pharmaceutical. Alternative Names: Cobicistat, GS-9350; GS 9350; GS9350. CAS No. 1004316-88-4. Pack Sizes: 25 mg. Product ID: B0084-456314. Molecular formula: C40H53N7O5S2. Mole weight: 776.028. Custom synthesis is available. Send your inquiries for more information. | London |
| N-[[[(1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]hydroxyphosphinyl]-D-alanine | An impurity of Tenofovir, which is an acyclic phosphonate nucleotide derivative, could be used in antiviral treatment as an everse transcriptase inhibitor. Group: Pharmaceutical. Alternative Names: GS 7160. CAS No. 376633-24-8. Pack Sizes: 50 mg. Product ID: B2694-085564. Molecular formula: C12H19N6O5P. Mole weight: 358.29. Custom synthesis is available. Send your inquiries for more information. | London |
Our database is helping our users find suppliers everyday.
